# Regulations.gov document: Reference 15 - U.S. Food and Drug Administration. S5(R3) Detection of Reproductive and Developmental Toxicity for Human
Pharmaceuticals: Guidance for Industry [Internet]. Silver Spring (MD): FDA; 2021 May [cited 2026 Aug 29]. Available
from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/s5r3-detection-reproductive-anddevelopmental-toxicity-human-pharmaceuticals — retained record

> Retained regulations record from regulations-gov.

Canonical: https://highsignal.app/data/records/576c94d6585f031b

[← sources](https://highsignal.app/data)

Pharmaceuticals: Guidance for Industry [Internet]. Silver Spring (MD): FDA; 2021 May [cited 2026 Aug 29]. Available
from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/s5r3-detection-reproductive-anddevelopmental-toxicity-human-pharmaceuticals

source: [regulations](https://highsignal.app/data/regulations) (regulations-gov)  published 2026-09-03 04:00 ingested 2026-09-04 02:44

[original source ↗](https://www.regulations.gov/document/FDA-2026-P-10297-0017)

## retained text



```
Query: data center
Agency: FDA
Type: Supporting & Related Material
Docket: FDA-2026-P-10297
```



document fetched 2026-09-04 02:44 · canonical https://regulations.gov/document/FDA-2026-P-10297-0017